Brown Advisory’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.1M Sell
376,547
-56,097
-13% -$5M 0.05% 248
2025
Q4
$34.2M Sell
432,644
-9,522
-2% -$747K 0.05% 248
2025
Q3
$35.3M Sell
442,166
-49,330
-10% -$4.21M 0.05% 247
2025
Q2
$44.7M Sell
491,496
-11,485
-2% -$1.05M 0.06% 207
2025
Q1
$47.1M Sell
502,981
-3,092
-0.6% -$277K 0.07% 192
2024
Q4
$46M Buy
506,073
+347,730
+220% +$33.2M 0.06% 222
2024
Q3
$16.4M Sell
158,343
-975
-0.6% -$99.4K 0.02% 349
2024
Q2
$15.5M Sell
159,318
-1,828
-1% -$169K 0.02% 354
2024
Q1
$14.5M Buy
161,146
+1,496
+0.9% +$127K 0.02% 359
2023
Q4
$12.7M Buy
159,650
+23,560
+17% +$1.77M 0.02% 376
2023
Q3
$9.68M Sell
136,090
-3,555
-3% -$266K 0.02% 389
2023
Q2
$10.8M Sell
139,645
-3,374
-2% -$261K 0.02% 390
2023
Q1
$10.7M Sell
143,019
-3,976
-3% -$296K 0.02% 384
2022
Q4
$11.6M Buy
146,995
+769
+0.5% +$57.7K 0.02% 375
2022
Q3
$10.3M Buy
146,226
+371
+0.3% +$29.1K 0.02% 373
2022
Q2
$11.7M Buy
145,855
+6,275
+4% +$491K 0.02% 361
2022
Q1
$10.6M Sell
139,580
-23,852
-15% -$1.89M 0.02% 383
2021
Q4
$13.9M Buy
163,432
+10,106
+7% +$789K 0.02% 365
2021
Q3
$11.6M Buy
153,326
+14,455
+10% +$1.15M 0.02% 360
2021
Q2
$11.3M Buy
138,871
+13,679
+11% +$1.12M 0.02% 363
2021
Q1
$9.87M Sell
125,192
-2,465
-2% -$193K 0.02% 353
2020
Q4
$10.9M Sell
127,657
-10,533
-8% -$871K 0.02% 327
2020
Q3
$10.7M Buy
138,190
+7,832
+6% +$597K 0.02% 309
2020
Q2
$9.55M Buy
130,358
+2,604
+2% +$185K 0.02% 315
2020
Q1
$8.48M Buy
127,754
+11,477
+10% +$809K 0.03% 309
2019
Q4
$8M Sell
116,277
-1,305
-1% -$89K 0.02% 356
2019
Q3
$8.64M Buy
117,582
+3,014
+3% +$219K 0.02% 340
2019
Q2
$8.21M Sell
114,568
-38,896
-25% -$2.76M 0.02% 345
2019
Q1
$10.5M Sell
153,464
-10,780
-7% -$696K 0.03% 344
2018
Q4
$9.78M Buy
164,244
+6,033
+4% +$377K 0.03% 331
2018
Q3
$10.6M Sell
158,211
-2,578
-2% -$172K 0.03% 329
2018
Q2
$10.4M Sell
160,789
-6,545
-4% -$428K 0.03% 322
2018
Q1
$12M Sell
167,334
-5,067
-3% -$365K 0.04% 279
2017
Q4
$13M Buy
172,401
+2,540
+1% +$185K 0.04% 278
2017
Q3
$12.4M Sell
169,861
-4,418
-3% -$318K 0.04% 278
2017
Q2
$12.9M Sell
174,279
-2,329
-1% -$173K 0.04% 278
2017
Q1
$12.9M Sell
176,608
-1,572
-0.9% -$110K 0.04% 260
2016
Q4
$11.7M Sell
178,180
-8,137
-4% -$558K 0.04% 267
2016
Q3
$13.8M Buy
186,317
+4,539
+2% +$336K 0.05% 251
2016
Q2
$13.3M Buy
181,778
+5,861
+3% +$417K 0.05% 246
2016
Q1
$12.4M Buy
175,917
+509
+0.3% +$33.9K 0.04% 242
2015
Q4
$11.7M Buy
175,408
+4,370
+3% +$291K 0.04% 263
2015
Q3
$10.9M Buy
171,038
+10,450
+7% +$683K 0.04% 262
2015
Q2
$10.5M Sell
160,588
-1,492
-0.9% -$101K 0.03% 272
2015
Q1
$11.2M Sell
162,080
-3,697
-2% -$256K 0.04% 266
2014
Q4
$11.5M Sell
165,777
-3,561
-2% -$240K 0.04% 253
2014
Q3
$11M Sell
169,338
-774
-0.5% -$51K 0.04% 256
2014
Q2
$11.6M Buy
170,112
+5,742
+3% +$385K 0.04% 243
2014
Q1
$10.7M Buy
164,370
+1,816
+1% +$114K 0.03% 252
2013
Q4
$10.6M Buy
162,554
+3,425
+2% +$219K 0.03% 242
2013
Q3
$9.44M Sell
159,129
-246
-0.2% -$14.6K 0.03% 250
2013
Q2
$9.13M Buy
+159,375
New +$9.46M 0.04% 235

Other funds holding CL

Brown Advisory's CL Position: Q1 2026 in Review

Brown Advisory reduced its Colgate-Palmolive (CL) stake by 13% in Q1 2026, selling an estimated $5M and leaving 376,547 shares worth $32.1M. The position accounts for 0.05% of the portfolio, ranked #248.

Brown Advisory first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $47.1M in Q1 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Brown Advisory held 376,547 shares of Colgate-Palmolive worth $32.1M as of Q1 2026.
  • Brown Advisory sold 56,097 Colgate-Palmolive shares in Q1 2026, an estimated $5M.
  • Colgate-Palmolive made up 0.05% of Brown Advisory's portfolio in Q1 2026, its #248 holding.
  • Brown Advisory first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Brown Advisory's Colgate-Palmolive position peaked at $47.1M in Q1 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.